KOD
Price
$12.48
Change
+$0.88 (+7.59%)
Updated
Oct 14 closing price
Capitalization
660.27M
28 days until earnings call
Intraday Buy/Sell Signals
QNCX
Price
$1.94
Change
-$0.02 (-1.02%)
Updated
Oct 14 closing price
Capitalization
103.94M
29 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

KOD vs QNCX

Header iconKOD vs QNCX Comparison
Open Charts KOD vs QNCXBanner chart's image
Kodiak Sciences
Price$12.48
Change+$0.88 (+7.59%)
Volume$905.14K
Capitalization660.27M
Quince Therapeutics
Price$1.94
Change-$0.02 (-1.02%)
Volume$200.67K
Capitalization103.94M
KOD vs QNCX Comparison Chart in %
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. QNCX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (KOD: $12.48 vs. QNCX: $1.94)
Brand notoriety: KOD and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 112% vs. QNCX: 70%
Market capitalization -- KOD: $660.27M vs. QNCX: $103.94M
KOD [@Biotechnology] is valued at $660.27M. QNCX’s [@Biotechnology] market capitalization is $103.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, QNCX is a better buy in the long-term than KOD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while QNCX’s TA Score has 6 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 4 bearish.
  • QNCX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а -12.30% price change this week, while QNCX (@Biotechnology) price change was +8.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2025.

QNCX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($660M) has a higher market cap than QNCX($104M). KOD YTD gains are higher at: 25.427 vs. QNCX (3.743). QNCX has higher annual earnings (EBITDA): -41.32M vs. KOD (-170.11M). KOD has more cash in the bank: 104M vs. QNCX (34.7M). QNCX has less debt than KOD: QNCX (17.5M) vs KOD (65.2M). KOD (0) and QNCX (0) have equivalent revenues.
KODQNCXKOD / QNCX
Capitalization660M104M635%
EBITDA-170.11M-41.32M412%
Gain YTD25.4273.743679%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M34.7M300%
Total Debt65.2M17.5M373%
FUNDAMENTALS RATINGS
KOD vs QNCX: Fundamental Ratings
KOD
QNCX
OUTLOOK RATING
1..100
8310
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3439
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNCX's Valuation (47) in the Biotechnology industry is in the same range as KOD (52). This means that QNCX’s stock grew similarly to KOD’s over the last 12 months.

QNCX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as KOD (100). This means that QNCX’s stock grew similarly to KOD’s over the last 12 months.

QNCX's SMR Rating (99) in the Biotechnology industry is in the same range as KOD (99). This means that QNCX’s stock grew similarly to KOD’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is in the same range as QNCX (39). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that KOD’s stock grew similarly to QNCX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODQNCX
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
80%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 8 days ago
89%
Bullish Trend 8 days ago
88%
MACD
ODDS (%)
Bearish Trend 8 days ago
82%
Bullish Trend 8 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 8 days ago
86%
Bullish Trend 8 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
89%
Bullish Trend 8 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 8 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVPEX13.430.13
+0.98%
ALPS Global Opportunity Portfolio Cl III
TGIHX16.46N/A
N/A
Nuveen Core Equity I
PRACX51.99-0.02
-0.04%
Putnam U.S. Research C
BRXAX16.88-0.07
-0.41%
MFS Blended Research Intl Eq A
WAIGX23.13-0.12
-0.52%
Wasatch International Growth Investor

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+7.59%
XNCR - KOD
45%
Loosely correlated
-10.96%
MBX - KOD
45%
Loosely correlated
-6.76%
MGNX - KOD
45%
Loosely correlated
-1.83%
IDYA - KOD
42%
Loosely correlated
+1.12%
MGX - KOD
41%
Loosely correlated
+1.75%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-1.02%
MNPR - QNCX
33%
Loosely correlated
-6.62%
KOD - QNCX
28%
Poorly correlated
+7.59%
SRZN - QNCX
24%
Poorly correlated
-1.30%
LQDA - QNCX
24%
Poorly correlated
-4.21%
MDXG - QNCX
24%
Poorly correlated
+1.08%
More